Prognostic value of PD-L1 in esophageal squamous cell carcinoma: a meta-analysis

Accumulated evidence has shown that the programmed cell death receptor 1/programmed cell death receptor 1 ligand 1 (PD-1/PD-L1) pathway is a promising therapeutic target for cancer immunotherapy. However, the association between PD-L1 and esophageal squamous cell carcinoma (ESCC) patient survival re...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wei, Wang, Pan, Li, Ning, Shao, Fei, Zhang, Hao, Yang, Zhenlin, Li, Renda, Gao, Yibo, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862626/
https://www.ncbi.nlm.nih.gov/pubmed/29568405
http://dx.doi.org/10.18632/oncotarget.23810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862626/
https://www.ncbi.nlm.nih.gov/pubmed/29568405
http://dx.doi.org/10.18632/oncotarget.23810

Ejemplares similares